Nucleic Acid‐Modified Nanoparticles for Cancer Therapeutic Applications
Small · 2025-07 · 21 (27)
DOI: 10.1002/smll.202500843 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 27.05.2025. Verfasst von Yunlong Qin und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, 91904, Israel. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles, Nucleic Acids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Ministry of Health.
Abstract (Originalsprache)
Nanomaterials including metal or metal oxide nanoparticles, carbonous nanomaterial (e.g., carbon dots) or metal–organic framework nanoparticles provide porous, catalytically active surfaces and functional interfaces for binding of ions or molecular agents. By the conjugation of nucleic acids to the nanoparticles, hybrid nanostructures revealing emerging multimodal catalytic/photocatalytic activities, high loading capacities, and effective targeted cell permeation efficacies are formed. The review article exemplifies the application of nucleic acid‐modified nanoparticles conjugates for therapeutic treatment of cancer cells. Stimuli‐responsive reconfiguration of nucleic acid strands and the specific recognition and catalytic function of oligonucleotides associated with porous, catalytic, and photocatalytic nanoparticles yield hybrid composites demonstrating cooperative synergistic properties for medical applications. The targeted chemodynamic, photodynamic, photothermal and chemotherapeutic treatment of cancer cells by the oligonucleotide/nanoparticle conjugates is addressed. In addition, the application of oligonucleotide/nanoparticle conjugates for gene therapy treatment of cancer cells is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, 91904, Israel.
ORCID-Profile: Itamar Willner
Förderung
- Israel Ministry of Health
Zitieren
APA
Qin, Y., Chen, X., & Willner, I. (2025). Nucleic Acid‐Modified Nanoparticles for Cancer Therapeutic Applications. Small, 21(27). https://doi.org/10.1002/smll.202500843
Vancouver
Qin Y, Chen X, Willner I. Nucleic Acid‐Modified Nanoparticles for Cancer Therapeutic Applications. Small. 2025;21(27). doi:10.1002/smll.202500843
BibTeX
@article{Qin2025,
author = {Qin, Yunlong and Chen, Xinghua and Willner, Itamar},
title = {Nucleic Acid‐Modified Nanoparticles for Cancer Therapeutic Applications},
journal = {Small},
year = {2025},
volume = {21},
number = {27},
doi = {10.1002/smll.202500843}
}
EUVIMED